Apatinib
Clinical trials for Apatinib explained in plain language.
Never miss a new study
Get alerted when new Apatinib trials appear
Sign up with your email to follow new studies for Apatinib, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a pill replace chemo for stomach cancer in the elderly?
Disease control Recruiting nowThis phase 2 trial tests whether apatinib, taken as a daily pill, can control advanced stomach or gastroesophageal junction cancer in people aged 65 and older who cannot or will not undergo chemotherapy. Participants receive apatinib until the disease worsens or side effects beco…
Matched conditions: APATINIB
Phase 2 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a blood vessel blocker stop Cancer-Related belly fluid?
Disease control Recruiting nowThis trial tests whether the oral drug apatinib can control malignant ascites, a painful buildup of fluid in the belly that can happen with advanced cancer. The study enrolls adults with persistent or symptomatic ascites that has not responded to standard treatments, including di…
Matched conditions: APATINIB
Phase 2 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo therapy aims to fight inoperable liver cancer
Disease control Recruiting nowThis phase 3 trial is testing whether adding two drugs—camrelizumab (an immunotherapy) and apatinib (a targeted therapy)—to a standard liver cancer procedure called TACE can help people with liver cancer that cannot be removed by surgery. The study will enroll 101 participants wi…
Matched conditions: APATINIB
Phase 3 • Sponsor: Guohui Xu • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC